10-Q: Bio Essence Corp. Q1 2026 Revenue Soars on OEM Services

Bio Essence Corp. reported a significant surge in revenue for the first quarter of 2026, driven by a substantial increase in OEM service orders.

Summary

• Bio Essence Corp. reported a net income of $205,373 for the three months ended March 31, 2026, a significant improvement from a net loss of $205,752 in the same period of 2025.
• Total revenues increased dramatically to $500,537 from $22,189 in the prior year's quarter, primarily due to a substantial rise in OEM service revenue.
• The company's gross profit also saw a significant increase, reaching $319,353 from $20,588.
• General and administrative expenses decreased by 54.30% to $102,878 from $225,137.
• The company had a working capital deficit of $1,371,877 as of March 31, 2026, with a current ratio of 0.37:1.
• Cash and equivalents stood at $36,177 as of March 31, 2026.
• The company is actively seeking additional financing and exploring new business opportunities, including potential acquisitions, to address its going concern issues.
• A significant legal proceeding has been initiated by Stason Industrial Corporation seeking approximately $1.5 million in damages for alleged breach of contract and lease obligations.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a cautiously optimistic report, with strong operational improvements and revenue growth, but significant ongoing concerns regarding going concern and legal liabilities.

Positives

• Significant revenue growth: Total revenues increased by 2,155.79% to $500,537 for the three months ended March 31, 2026, compared to $22,189 in the same period of 2025.
• Turnaround to profitability: The company reported a net income of $205,373 for the quarter, a substantial improvement from a net loss of $205,752 in the prior year.
• Increased gross profit: Gross profit rose to $319,353 from $20,588, reflecting improved operational efficiency or pricing power.
• Reduced operating expenses: General and administrative expenses decreased by 54.30% to $102,878.
• Successful equity issuance: The company raised $440,000 through the issuance of 8,800,000 shares of common stock in a private placement.
• Repayment of related party loan: The company received full repayment of a $375,173 loan from its senior officer.

Negatives

• Substantial doubt about going concern: The company's accumulated deficit of $9,347,700 and dependence on additional financing raise substantial doubt about its ability to continue as a going concern.
• Working capital deficit: A working capital deficit of $1,371,877 and a current ratio of 0.37:1 indicate short-term liquidity challenges.
• Low cash balance: Cash and equivalents were only $36,177 as of March 31, 2026.
• Significant legal liability: A lawsuit from Stason Industrial Corporation seeks approximately $1.5 million in damages, with management deeming a loss probable.
• Ineffective internal controls: Management concluded that disclosure controls and procedures, as well as internal control over financial reporting, were not effective as of March 31, 2026.

Risks

• The company's ability to continue as a going concern is dependent on its ability to implement its business plan, generate sufficient revenue, and raise additional funds through public or private offerings.
• A lawsuit filed by Stason Industrial Corporation alleges breach of contract and lease obligations, seeking approximately $1.5 million in damages. Management believes a loss is probable.
• The company has identified significant deficiencies in its disclosure controls and procedures and internal control over financial reporting, indicating potential risks in accurate and timely reporting.
• Concentration of revenue: For the three months ended March 31, 2026, one major customer accounted for 49.9% of total sales, posing a risk if this customer's business is lost.
• The company may have difficulty meeting upcoming cash requirements and may need to secure additional financing, which may result in dilution to existing shareholders.

Future Outlook

The company plans to increase income by strengthening its sales force, providing attractive sales incentive programs, and increasing marketing and promotion activities. Management also intends to raise additional funds through private or public offerings, or by obtaining loans from banks or others. The company believes in the viability of its strategy to generate sufficient revenue and its ability to raise additional funds, but there can be no assurances to that effect. The company is also exploring other business opportunities, including expanding its OEM business and looking for potential acquisition targets.

Management Comments

• Management believes that the Company's accumulated deficit and dependence on additional financing continue to raise substantial doubt about the Company's ability to continue as a going concern.
• Management intends to raise funds by way of a private or public offering, or by obtaining loans from banks or others.
• Management believes the $1.5 million operating lease liabilities recorded as of March 31, 2026 and December 31, 2025 represents the most likely outcome of the Stason Industrial Corporation matter.
• Management does not believe it is reasonably possible that a loss materially in excess of the amount accrued will be incurred in the Stason Industrial Corporation matter.
• Management concluded that a loss related to the SOW claim (part of the Stason litigation) was neither probable nor reasonably estimable as of March 31, 2026.

Industry Context

StockSavvy.ai notes that Bio Essence Corp.'s significant revenue increase in OEM services aligns with a broader industry trend where companies are focusing on higher-margin service-based revenue streams rather than direct product sales, especially in the competitive health supplement market.

Comparison to Industry Standards

• The revenue growth of 2,155.79% in OEM services significantly outpaces typical growth rates for the health supplement manufacturing sector, which often sees single to low double-digit annual growth.
• The shift to profitability from a net loss is a positive indicator, though the company's overall financial health (indicated by the going concern warning and working capital deficit) suggests it is still in a recovery or turnaround phase compared to more established, stable players in the industry.
• The company's reliance on a single major customer for nearly 50% of its revenue in the quarter is a higher concentration than typically observed in larger, more diversified companies within the health and wellness industry, which often aim for broader customer bases to mitigate risk.

Corporate Governance

Legal Proceedings

• On March 9, 2026, Stason Industrial Corporation filed a complaint alleging breach of contract and lease obligations, seeking approximately $1.5 million in damages. The company denies the allegations and intends to bring counterclaims.
• The company has accrued approximately $1.5 million related to the Stason Industrial Corporation matter, which management believes represents the most likely outcome.

Related Party Transactions

• As of March 31, 2026, the Company had loans to one major shareholder (also the Company's senior officer) of $375,173. This loan was fully repaid subsequent to the period end.
• As of December 31, 2025, the Company had loans to one major shareholder of $385,173. $380,000 was repaid on March 20, 2026.

Stakeholder Impact

• Shareholders: Potential dilution from future equity offerings to fund operations; positive impact from improved financial performance in the quarter.
• Creditors: Potential concern due to the going concern warning and working capital deficit, though the company is actively seeking financing.
• Employees: Continued employment is dependent on the company's ability to secure funding and improve financial stability.
• Suppliers: The company has significant advances to vendors ($247,500 as of March 31, 2026), indicating ongoing business relationships.

Next Steps

• Continue to strengthen sales force, provide attractive sales incentive programs, and increase marketing and promotion activities.
• Explore and implement strategies to raise additional funds through private or public offerings, or loans.
• Seek other business opportunities, including expanding OEM business and looking for potential acquisition targets.
• Participate in the legal process regarding the Stason Industrial Corporation lawsuit.
• Continue to work on implementing controls and procedures to remedy the ineffectiveness of disclosure controls and procedures and internal control over financial reporting.

Key Dates

Recommendation

The company shows significant operational improvement with a strong revenue surge and return to profitability, which is positive. However, the persistent going concern warning, substantial accumulated deficit, and a significant ongoing legal proceeding demanding $1.5 million necessitate caution. While the recent capital raise and acquisition are promising, the overall financial precariousness and ineffective internal controls warrant a 'hold' recommendation until these critical issues are demonstrably resolved.

Keywords

Bio Essence Corp, Form 10-Q, Quarterly Report, OEM Services, Health Supplements, Financial Statements, Revenue Growth, Net Income, Going Concern, Legal Proceedings, Internal Controls